Finance

Beta
Lists
ELTX:NASDAQ
Elicio Therapeutics Inc
$4.05
+1.25%
(+0.050) 1D
Jun 30, 9:39:41 AM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for ELTX...
Open
$4.00
High
$4.10
Low
$4.00
Mkt. cap
77.77M
Avg. vol.
2.73M
Volume
9.67K
52-wk high
$16.00
52-wk low
$2.66
EPS
-$2.41
Beta
1.13
Shares outstanding
19.09M
No. of employees
33
Open
$4.00
High
$4.10
Low
$4.00
Mkt. cap
77.77M
Avg. vol.
2.73M
Volume
9.67K
52-wk high
$16.00
52-wk low
$2.66
EPS
-$2.41
Beta
1.13
Shares outstanding
19.09M
No. of employees
33
News stories
From sources across the web
About Elicio Therapeutics Inc
CEO-
Employees33
Founded2011
HeadquartersBoston, Massachusetts, United States
SectorBiotechnology
Websiteelicio.com
Analyst ratings
Based on 4 analysts giving stock ratings to ELTX in the past 3 months
Strong buy
Buy
3
Hold
1
Sell
0
12-month forecast
Based on 4 Wall Street analysts offering 12 month price targets for ELTX in the last 3 months.
Highest
Current $4.05
$27.00 (+566.67%)
Average
$20.67 (+410.37%)
Lowest
$12.00 (+196.30%)
Analyst
Recommendation
Action
Price target
Projected
Date
Boris Peaker
JonesTrading
Hold
Reiterated
-
-
06/24/2026
Robert Burns
H.C. Wainwright
Buy
Reiterated
$23.00
+467.9%
06/22/2026
Kevin DeGeeter
Ladenburg Thalmann & Co.
Buy
Initiated
$12.00
+196.3%
06/18/2026
Mayank Mamtani
B. Riley Securities
Buy
Initiated
$27.00
+566.7%
06/10/2026
Aydin Huseynov
Ladenburg Thalmann & Co.
Buy
Initiated
$20.00
+393.8%
04/15/2026
Soumit Roy
JonesTrading
Buy
Maintained
$18.00
+344.4%
04/06/2026
Michael King
Rodman & Renshaw
Buy
Initiated
$17.00
+319.8%
03/09/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
7.01M
5.04M
5.08M
6.76M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
3.08M
3.01M
3.76M
3.84M
Operating expense
10.09M
8.04M
8.84M
10.60M
Total operating expenses
10.09M
8.04M
8.84M
10.60M
Operating income
-10.09M
-8.04M
-8.84M
-10.60M
Other non operating income
-859.00K
-1.81M
1.26M
-984.00K
EBT including unusual items
-10.56M
-10.08M
-7.72M
-11.82M
EBT excluding unusual items
-10.98M
-10.08M
-7.72M
-11.82M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-10.56M
-10.08M
-7.72M
-11.82M
Net profit margin
-
-
-
-
Earnings per share
-0.66
-0.60
-0.49
-0.65
Interest and investment income
168.00K
199.00K
199.00K
157.00K
Interest expense
-194.00K
-426.00K
-337.00K
-407.00K
Net interest expenses
-26.00K
-227.00K
-138.00K
-250.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-10.04M
-8.00M
-8.79M
-10.56M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer